| |
| |
|
| Insider
Information: |
Theuer Charles |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
453,445 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$108,787 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
453,445 |
|
|
| Total
Value |
$108,787 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
39
|
0
|
|
Stock
price went up :
|
18
|
0
|
| Stock
price went down : |
21
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 102.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tracon Pharmaceuticals, Inc. |
TCON |
|
2023-10-20 |
406,417 |
|
0 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
Director |
2019-06-07 |
14,677 |
2019-06-07 |
0 |
Premium* |
|
|
4d Molecular Therapeutics Inc. |
FDMT |
Director |
2020-12-10 |
32,351 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TCON |
Tracon Pharmaceuticals, I... |
President and CEOOfficer |
• • – |
2015-01-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,616 |
|
- |
|
| FDMT |
4d Molecular Therapeutics... |
Director |
– • – |
2020-12-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
32,351 |
|
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2016-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
90,900 |
93,400 |
0 |
- |
|
| ONCT |
Oncternal Therapeutics In... |
Director |
– • – |
2019-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,677 |
14,677 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
PRESIDENT AND CEO |
• • – |
2023-10-20 |
4 |
A |
$0.13 |
$467 |
D/D |
3,500 |
406,417 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
PRESIDENT AND CEO |
• • – |
2023-04-20 |
4 |
A |
$0.14 |
$482 |
D/D |
3,500 |
402,917 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2019-08-09 |
4 |
B |
$0.45 |
$22,500 |
D/D |
50,000 |
173,565 |
2.81 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2018-12-21 |
4 |
B |
$0.66 |
$32,222 |
D/D |
49,000 |
132,855 |
2.81 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-04-26 |
4 |
B |
$0.66 |
$2,639 |
D/D |
3,999 |
352,417 |
2.73 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2015-09-18 |
4 |
OE |
$0.70 |
$7,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-04-27 |
4 |
B |
$0.75 |
$35,250 |
D/D |
47,000 |
399,417 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2019-01-22 |
4 |
D |
$1.04 |
$9,663 |
D/D |
(9,290) |
123,565 |
0 |
- |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2020-03-13 |
4 |
B |
$1.13 |
$4,624 |
D/D |
4,100 |
50,877 |
2.73 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2020-03-12 |
4 |
B |
$1.17 |
$11,803 |
D/D |
10,000 |
46,777 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-12-14 |
4 |
B |
$1.29 |
$29,755 |
D/D |
23,000 |
333,118 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-11-18 |
4 |
B |
$1.41 |
$19,599 |
D/D |
13,900 |
310,118 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-11-03 |
4 |
B |
$1.52 |
$13,984 |
D/D |
9,200 |
296,218 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-02-28 |
4 |
B |
$1.52 |
$304 |
D/D |
200 |
340,118 |
2.73 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-03-01 |
4 |
B |
$1.52 |
$7,296 |
D/D |
4,800 |
344,918 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2020-08-21 |
4 |
B |
$1.56 |
$8,307 |
D/D |
5,325 |
171,882 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2020-08-20 |
4 |
B |
$1.58 |
$47,400 |
D/D |
30,000 |
166,557 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2022-11-02 |
4 |
B |
$1.59 |
$9,540 |
D/D |
6,000 |
287,018 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2023-01-18 |
4 |
B |
$1.62 |
$11,016 |
D/D |
6,800 |
339,918 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2020-08-18 |
4 |
B |
$1.63 |
$72,851 |
D/D |
44,743 |
136,557 |
2.81 |
% |
|
| TCON |
Tracon Pharmaceuticals, I... |
President and CEO |
• • – |
2020-08-13 |
4 |
B |
$1.65 |
$8,250 |
D/D |
5,000 |
91,714 |
2.81 |
% |
|
57 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
